# Innovation Pathways, LLC

Canonical: https://abierto.us/vendors/innovation-pathways-llc-nahev73jlxh3

- UEI: NAHEV73JLXH3
- CAGE: 69G96
- Location: Palo Alto, CA
- Awards in window: 2 (8 transactions), $2,107,745 obligated, January 18, 2024 to July 28, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $2,107,745

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $2,108,949
- 541713 Research and Development in Nanotechnology: -$1,204

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75N93023C00014 (definitive contract): $2,108,949, National Institutes of Health Niaid. The Pharmacological Development of IPW-5371 Fumarate as a Radiation Medical Countermeasure for the Treatment of Delayed Radiation Lung Injury Under the FDA Animal Rule. https://www.usaspending.gov/award/CONT_AWD_75N93023C00014_7529_-NONE-_-NONE-/
- HHSN272201800012C (definitive contract): -$1,204, National Institutes of Health Niaid. To De-Obligate Remaining Funds and Administratively Close the Contract.. https://www.usaspending.gov/award/CONT_AWD_HHSN272201800012C_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/innovation-pathways-llc-nahev73jlxh3.